L.M. Litchfield

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

L.M. Litchfield is an author at Dana-Farber Cancer Institute specializing in cancer immunotherapy, metastatic breast cancer treatment, and her2-positive breast cancer.

Publications per year

2022–2022

Publications

LBA18 Final overall survival (OS) for abemaciclib plus trastuzumab +/- fulvestrant versus trastuzumab plus chemotherapy in patients with HR+, HER2+ advanced breast cancer (monarcHER): A randomized, open-label, phase II trial

Fabrice André, Jorge Nadal, Hannelore Denys et al. · Annals of Oncology · 2022 · 17 citations

Medicine, Oncology, Pharmacology +17

1–1 of 1